Paolo Verdecchia

29.9k total citations · 7 hit papers
317 papers, 16.8k citations indexed

About

Paolo Verdecchia is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Paolo Verdecchia has authored 317 papers receiving a total of 16.8k indexed citations (citations by other indexed papers that have themselves been cited), including 264 papers in Cardiology and Cardiovascular Medicine, 61 papers in Endocrinology, Diabetes and Metabolism and 48 papers in Surgery. Recurrent topics in Paolo Verdecchia's work include Blood Pressure and Hypertension Studies (187 papers), Heart Rate Variability and Autonomic Control (75 papers) and Cardiovascular Health and Disease Prevention (52 papers). Paolo Verdecchia is often cited by papers focused on Blood Pressure and Hypertension Studies (187 papers), Heart Rate Variability and Autonomic Control (75 papers) and Cardiovascular Health and Disease Prevention (52 papers). Paolo Verdecchia collaborates with scholars based in Italy, United States and United Kingdom. Paolo Verdecchia's co-authors include Gianpaolo Reboldi, Fabio Angeli, Carlo Porcellati, Giuseppe Schillaci, Claudia Borgioni, Giuseppe Mancia, Roberto Gattobigio, Claudio Cavallini, Antonio Spanevello and Antonella Ciucci and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Paolo Verdecchia

302 papers receiving 16.1k citations

Hit Papers

European Society of Hypertension recommendations for co... 1990 2026 2002 2014 2003 1990 2020 2001 2005 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement
    2003 1.3k citations Giuseppe Mancia, Josep Redón et al. profile →
  2. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension.
    1990 988 citations Paolo Verdecchia, Giuseppe Schillaci et al. Circulation profile →
  3. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
    2020 908 citations Paolo Verdecchia, Claudio Cavallini et al. European Journal of Internal Medicine profile →
  4. Prognostic Significance of Endothelial Dysfunction in Hypertensive Patients
    2001 850 citations Roberto Ceravolo, Paolo Verdecchia et al. Circulation profile →
  5. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement
    2005 550 citations Giuseppe Mancia, Josep Redón et al. profile →
  6. Prognostic Significance of Serial Changes in Left Ventricular Mass in Essential Hypertension
    1998 520 citations Paolo Verdecchia, Giuseppe Schillaci et al. Circulation profile →
  7. Prognostic Effect of the Nocturnal Blood Pressure Fall in Hypertensive Patients
    2016 367 citations Gianpaolo Reboldi, Paolo Verdecchia et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paolo Verdecchia Italy 59 12.6k 2.7k 2.5k 1.5k 1.2k 317 16.8k
Gianpaolo Reboldi Italy 52 8.1k 0.6× 2.0k 0.7× 2.3k 0.9× 1.1k 0.7× 1.4k 1.2× 259 14.3k
Franz H. Messerli United States 80 16.2k 1.3× 3.2k 1.2× 5.5k 2.2× 2.4k 1.6× 1.8k 1.5× 415 22.9k
Giuseppe Schillaci Italy 62 11.7k 0.9× 2.7k 1.0× 2.3k 0.9× 1.2k 0.8× 1.5k 1.3× 217 16.4k
George S. Stergiou Greece 57 11.6k 0.9× 3.7k 1.4× 1.4k 0.6× 1.7k 1.1× 918 0.8× 379 15.6k
Massimo Volpe Italy 72 11.7k 0.9× 2.9k 1.1× 3.8k 1.5× 1.3k 0.9× 2.7k 2.3× 844 21.5k
Michel Burnier Switzerland 66 7.3k 0.6× 1.8k 0.7× 3.5k 1.4× 2.1k 1.4× 1.4k 1.2× 605 17.1k
Chim C. Lang United Kingdom 65 8.8k 0.7× 2.6k 1.0× 3.0k 1.2× 445 0.3× 1.9k 1.6× 394 16.1k
Susan Cheng United States 66 8.1k 0.6× 1.8k 0.6× 1.6k 0.6× 811 0.5× 3.6k 3.0× 346 18.0k
Felix Mahfoud Germany 57 10.4k 0.8× 2.3k 0.8× 1.6k 0.7× 1.6k 1.1× 627 0.5× 502 12.4k
Frank Ruschitzka Switzerland 61 14.8k 1.2× 3.8k 1.4× 1.9k 0.8× 446 0.3× 1.6k 1.3× 384 21.4k

Countries citing papers authored by Paolo Verdecchia

Since Specialization
Citations

This map shows the geographic impact of Paolo Verdecchia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Verdecchia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Verdecchia more than expected).

Fields of papers citing papers by Paolo Verdecchia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Verdecchia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Verdecchia. The network helps show where Paolo Verdecchia may publish in the future.

Co-authorship network of co-authors of Paolo Verdecchia

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Verdecchia. A scholar is included among the top collaborators of Paolo Verdecchia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Verdecchia. Paolo Verdecchia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Verdecchia, Paolo, Gianpaolo Reboldi, Giovanni Mazzotta, Martina Zappa, & Fabio Angeli. (2024). Ipertensione arteriosa secondaria: diagnosi e trattamento. Giornale italiano di cardiologia. 25(9). 660–672.
2.
Verdecchia, Paolo & Pasquale Perrone Filardi. (2024). Linee guida europee sull’ipertensione: cosa c’è di nuovo?. Giornale italiano di cardiologia. 25(11). 765–773.
3.
Angeli, Fabio, Martina Zappa, & Paolo Verdecchia. (2023). Newer COVID-19 vaccines: Still lights and shadows?. European Journal of Internal Medicine. 118. 32–35. 1 indexed citations
4.
Bo, Mario, Stefano Fumagalli, Luca Degli Esposti, et al.. (2023). Anticoagulation in atrial fibrillation. A large real-world update. European Journal of Internal Medicine. 121. 88–94. 15 indexed citations
5.
Verdecchia, Paolo, Giuseppe Murdolo, Stefano Coiro, et al.. (2023). Therapy of Type 2 diabetes: more gliflozines and less metformin?. European Heart Journal Supplements. 25(Supplement_B). B171–B176. 6 indexed citations
6.
Angeli, Fabio, Gianpaolo Reboldi, & Paolo Verdecchia. (2023). Target pressorio nel paziente iperteso anziano. Giornale italiano di cardiologia. 24(4). 305–309.
7.
Angeli, Fabio, Martina Zappa, & Paolo Verdecchia. (2023). Global burden of new-onset hypertension associated with severe acute respiratory syndrome coronavirus 2 infection. European Journal of Internal Medicine. 119. 31–33. 4 indexed citations
8.
Angeli, Fabio, et al.. (2022). Ipertensione dopo vaccinazione anti-COVID-19. Giornale italiano di cardiologia. 23(1). 10–14. 11 indexed citations
9.
Angeli, Fabio, Jacopo Marazzato, Paolo Verdecchia, et al.. (2021). Joint effect of heart failure and coronary artery disease on the risk of death during hospitalization for COVID-19. European Journal of Internal Medicine. 89. 81–86. 17 indexed citations
10.
Verdecchia, Paolo & Fabio Angeli. (2021). Progressi nel trattamento dell’ipertensione arteriosa. Giornale italiano di cardiologia. 22(4). 253–266. 1 indexed citations
11.
Verdecchia, Paolo, Fabio Angeli, & Gianpaolo Reboldi. (2021). Lo studio STEP: a quali livelli ridurre la pressione arteriosa nei pazienti ipertesi?. Giornale italiano di cardiologia. 22(12). 981–983.
12.
13.
Sayadi, Mehrab, et al.. (2020). Impact of type II diabetes and gender on major clinical events after percutaneous coronary intervention. Primary care diabetes. 15(2). 347–351. 2 indexed citations
14.
Angeli, Fabio, et al.. (2020). Device-Pocket Hematoma after Cardiac Implantable Electronic Devices. Circulation Arrhythmia and Electrophysiology. 13(4). e008372–e008372. 10 indexed citations
15.
Hijazi, Ziad, Paolo Verdecchia, Jonas Oldgren, et al.. (2019). Cardiac biomarkers and left ventricular hypertrophy in relation to outcomes in patients with atrial fibrillation: Experiences from the RE-LY trial. IrInSubria (University of Insubria). 15 indexed citations
16.
Pinto, Maurizio Del, Claudia Castellani, Gianluca Zingarini, et al.. (2019). Uno strano caso di sindrome Takotsubo dopo eco-stress con dipiridamolo. Giornale italiano di cardiologia. 20(9). 529–532.
17.
Colonna, Paolo, Maurizio Giuseppe Abrignani, Furio Colivicchi, et al.. (2013). Documento ANMCO su prevenzione del tromboembolismo nella fibrillazione atriale e ruolo dei nuovi anticoagulanti orali. Giornale italiano di cardiologia. 14(4). 295–322. 5 indexed citations
18.
19.
Schillaci, Giuseppe, Paolo Verdecchia, Gianpaolo Reboldi, Sergio Pede, & Carlo Porcellati. (2000). Subclinical left ventricular dysfunction in systemic hypertension and the role of 24-hour blood pressure. The American Journal of Cardiology. 86(5). 509–513. 16 indexed citations
20.
Agabiti‐Rosei, Enrico, Ezio Giovannini, Giuseppe Mancia, et al.. (1999). [Arterial hypertension and cardiac pathology. Diagnostic and therapeutic guidelines presented by the Joint Commission of the ANMCO-SIC-SIIA. Assoziane Nazionale Medici Cardiologi Ospedalieri. Società Italiana di Cardiologia. Società Italiana dell'Ipertensione Arteriosa].. PubMed. 29(3). 341–56. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gianpaolo Reboldi Breakdown of academic impact, for papers by Franz H. Messerli Breakdown of academic impact, for papers by Giuseppe Schillaci Breakdown of academic impact, for papers by George S. Stergiou Breakdown of academic impact, for papers by Massimo Volpe Breakdown of academic impact, for papers by Michel Burnier Breakdown of academic impact, for papers by Chim C. Lang Breakdown of academic impact, for papers by Susan Cheng Breakdown of academic impact, for papers by Felix Mahfoud Breakdown of academic impact, for papers by Frank Ruschitzka
Rankless by CCL
2026